Last month, in our first issue of these special edition newsletters we gave you the tools to become an expert on SGLT2-I therapy. In our second edition we want to help you dig deeper into this new class of drugs. To that end we have some great information for you. …

Recently, I was chatting electronically with Irl B. Hirsch, MD, Diabetes Treatment and Teaching Chair at the University of Washington School of Medicine. I asked him if he had been using Invokana with his patients, and he sent me back this message: “No, not yet, and not likely to anytime soon …

Often, when a new class of drugs receives FDA approval, we hear from the investigators or medical professionals involved in the original studies and clinical trials and, although they may possess the most knowledge, they are often the least likely to fairly represent the opinions of most medical professionals. For …

David Joffe, BSPharm, CDE, Editor-in-chief, Diabetes In Control Lauren Self, University of Florida College of Pharmacy, PharmD Candidate When the finest, most talented endocrinologists get together for a conference, you can bet that there will be a lot of great information on the latest in diabetes care. This year it …

We often talk about the value of controlling lipids and glucose and their relation to patient health. If patients would only do what we tell them then the results would be good and our jobs would be easier. With the recent changes in healthcare, however, going through the motions of …

  This week, we continue with our Homerun Slides series on quality reporting, with some facts and data to help you in further understanding how Accountable Care Organizations fit into the picture.

Konstantinos Makrilakis, MD, PhD Nikolaos Katsilambros, MD, PhD.  Clinical management The management of HHS is similar to that of DKA. It includes correction of the fluid and electrolyte abnormalities that are typically present and administration of insulin. 1,3,15 Therapy should also aim at simultaneous identification and treatment of the precipitating …

This past week we had our PharmD candidate, Lauren Self, scour the information from the AACE meeting in Phoenix, in order to prepare the best articles for you to review. The new AACE guidelines that Dr. Alan Garber delivered during the meeting focused on a tailored approach with increased use …

CAD Risk for Pre-Diabetes Comparable to Diabetes See this week’s Item #3.

  BUZZY for Pain Free Injections  Buzzy® is simply a small vibrating bee with a unique ice pack. Put it near any sharp, itching or burning pain, and using natural pain relief, Buzzy desensitizes the body’s nerves, dulling or eliminating sharp injection pain. In the same way that rubbing a bumped …